Tildrakizumab for the treatment of moderate to severe psoriasis: Results from a single center preliminary real‐life study
Angelo Ruggiero, Luca Potestio, Sara Cacciapuoti, Lucia Gallo, Teresa Battista, Elisa Camela, Gabriella Fabbrocini, Matteo Megna
Topics & Concepts
MedicineSection (typography)PsoriasisDermatologyAdvertisingBusinessPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesAutoimmune Bullous Skin Diseases